Cargando…
Non-hyperammonaemic valproate encephalopathy after 20 years of treatment
Sodium valproate is a commonly used antiseizure drug with broad indications for different seizuretypes and epilepsy syndromes. Well-recognised side effects include weight gain, tremor, dizziness, and unsteadiness. Non-hyperammonaemic parkinsonism, with or without cognitive impairment, is a rare adve...
Autores principales: | Caruana Galizia, Elizabeth, Isaacs, Jeremy D., Cock, Hannah R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470621/ https://www.ncbi.nlm.nih.gov/pubmed/28649495 http://dx.doi.org/10.1016/j.ebcr.2017.04.002 |
Ejemplares similares
-
Acute hyperammonaemic encephalopathy
por: Ng, Peng Soon, et al.
Publicado: (2014) -
Hyperammonaemic encephalopathy: a remarkably rare complication after bariatric surgery
por: Jhamb, Shaurya, et al.
Publicado: (2023) -
Hyperammonaemic Encephalopathy Caused by Adult-Onset Ornithine Transcarbamylase Deficiency
por: Niclasen, Bjarke Hammer, et al.
Publicado: (2022) -
Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant
por: Shipton, Michael J., et al.
Publicado: (2022) -
Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014)